Potential conflict of interest: Consultancy for Abbott, Astellas, Axcan, GalMed, Genfit, Gilead, Intercept, Roche and Sanofi-Aventis.
Management of nonalcoholic steatohepatitis: Pharmacotherapy
Version of Record online: 25 SEP 2012
© 2012 the American Association for the Study of Liver Diseases
Clinical Liver Disease
Special Issue: Non-alcoholic Fatty Liver Disease
Volume 1, Issue 4, pages 122–124, September 2012
How to Cite
Ratziu, V. (2012), Management of nonalcoholic steatohepatitis: Pharmacotherapy. Clinical Liver Disease, 1: 122–124. doi: 10.1002/cld.74
- Issue online: 25 SEP 2012
- Version of Record online: 25 SEP 2012
- 4The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012;142:1592-1609., , , , , , et al.